Company: PFSA
Filing Date: 2025-06-09
Form Type: 425
Source: 0001213900-25-052488
Chunk: 2

Company: Profusa, Inc.
Filing Date: 2025-06-09
Form: 425
Chunk 2
---
 instead purchase such shares.
The parties agreed that such purchases would be structured in compliance with the requirements of Rule 14e-5 under the Exchange
Act or would otherwise not constitute a tender offer pursuant to the Exchange Act, including the waiver of any redemption rights
on such purchased securities.

Pursuant to the Non-Redemption Agreement, the Investors purchased 100,000
shares of the Company’s common stock at a price of $12.51 from a hedge fund that owned less than 5% of the outstanding common stock
of the Company. The Non-Redemption Agreement may reduce the number of NorthView common stock redeemed in connection with the Company’s
Business Combination, and such reduction could alter the perception of the potential strength of the Business Combination. The purpose
of the Non-Redemption Agreement, and the purchases thereunder, is to increase the cash available to the Company upon the closing of the
Business Combination. The Non-Redemption Agreement purchases are not expected to impact the likelihood of approval of the Merger Agreement
and the Business Combination by the Company’s stockholders, however, the resulting additional cash proceeds available at the closing
of the Business Combination could potentially increase the likelihood of Nasdaq approving the listing of the Company’s securities
at such closing of the Business Combination. In connection with the special meeting of stockholders to approve the Business Combination,
stockholders of the Company redeemed 52,784 shares of common stock.

The foregoing summary of the Non-Redemption Agreement
does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed
herein as Exhibit 10.1 and incorporated herein by reference.

Adjournment of Special Meeting of Stockholders

On June 9, 2025, the Company
announced that the special meeting of stockholders to approve the Business Combination, which was originally scheduled for 10:00 a.m.
Eastern time on June 9, 2025, was adjourned.

The Special Meeting will reconvene on June 9, 2025,
at 4:30 p.m., Eastern time, via a live teleconference. Visit at https://www.cleartrustonline.com/NVAC for details to attend the
meeting.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits:

| Exhibit 
 No.     
 10.1    |     | Description                                                                                 
 Non-Redemption Agreement                                                                    
 (incorporated by reference to Exhibit